![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Switzerland
Find below all kinds of persons from Switzerland (Schweiz / Suisse).Total search results: 1254 | Ordered by Person (ascending)
1 2 3 4 5 6 7 8 9 10 11 12 13 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO) | Chief Executive Officer (CEO) | CRISPR Therapeutics (Group) | Northwestern Switzerland (region) |
| Kull, Toomas (Cabinet Privé de Conseils 202009) | Public Relations Manager / Investor Relations Manager | Cabinet Privé de Conseils S.A. | Région Lémanique (region) |
| Kumar, Karthiga (Invasight 202206 CEO + CSO + Co-Founder) | Chief Executive Officer (CEO) | Invasight AG | Zürich (region) |
| Kuner, Michael (Nycomed 200802– Executive VP) | Legal Manager | Takeda (Group) | Zürich (region) |
| Kurz, Allison (Genedata 201004 Marketing & Communication) | Public Relations Manager / Investor Relations Manager | Genedata (Group) | Northwestern Switzerland (region) |
| Kutzer, Stephan (Lonza 201302– COO before 200807 Head of Biopharma) | Chief Operating Officer (COO) | Lonza (Group) | Northwestern Switzerland (region) |
| Kwee, Ivo (BigOmics 202203 CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | BigOmics Analytics S.A. | Switzerland_other |
| Kübler, Olaf | n. a. | ETH Zürich (ETHZ) | Zürich (region) |
| Kühner, Markus (Adolf Kühner AG 200905 CEO) | Chief Executive Officer (CEO) | Adolf Kühner AG | Northwestern Switzerland (region) |
| König, Anja (Novartis 200910 Novartis Venture Fund) | Investment Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Ladestein, Paul (MyCartis 201409– CEO before Biocartis 201404 Managing Director of business unit Evalution + Luminex) | Chief Executive Officer (CEO) | MyCartis | Région Lémanique (region) |
| Lahn, Michael (iOnctura 201903– CMO before Incyte + AstraZeneca + Lilly) | Chief Medical Officer (CMO) | iOnctura (Group) | Région Lémanique (region) |
| Lamotte, André (HBM BioVentures 200505) | n. a. | HBM (Group) | Central Switzerland (region) |
| Lang, Steffen (Novartis 201803 Global Head Technical Operations joined 1994) | Board member, executive | Novartis (Group) | Northwestern Switzerland (region) |
| Lange, Dirk T. (Merck (DE) 202202– EVP Global Head of Life Science Services at MilliporeSigma before JSR Corp) | Chief Executive Officer (CEO) | MilliporeSigma (business unit of Merck KGaA) | Massachusetts (federal state) |
| Langen, Hanno (Roche 200902 GLobal Head Protein Biomarker Technologies Roche Molecular Medicine Laboratories) | Product Manager (personnel) | Roche (Group) | Northwestern Switzerland (region) |
| Langenegger, Lukas (Hemotune 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | Hemotune AG | Zürich (region) |
| Lapid, Henit (Lonza 202104 Head Mammalian Commercial Development + Marketing) | Sales Manager / Marketing Manager | Lonza (Group) | Northwestern Switzerland (region) |
| Lapray, Damien (Hedera Dx 202210 CCO + Co-Founder before Sophia Genetics) | Chief Commercial Officer (CCO) | Hedera Dx S.A. | Région Lémanique (region) |
| Lassen, Cheryl (Cytos Biotechnology 201303– VP Clinical Development before Novartis + BMS + Abbott + Pharmacia) | Clinical Research Manager | Kuros (Group) | Zürich (region) |
| Latrille, Frank (Merck Serono 200701 Head of Product Development) | n. a. | Merck (DE) (Group) | Région Lémanique (region) |
| Lauber, Wendy (Tecan 201109 Head Product Management for Liquid Handling + Consumables) | Product Manager (personnel) | Tecan (Group) | Zürich (region) |
| Laue, Carsten (Medipol 201108 Managing Director) | Managing Director | Medipol S.A. | Région Lémanique (region) |
| Lehn, Jean-Marie (Therascope founder) | Company Founder | Amgen (Group) | Germany (state/region unspecified) |
| Lehtonen, Tommi (Hedera Dx 202209 CEO + +Co-Founder before Blueprint Genetics 201707 CEO) | Chief Executive Officer (CEO) | Hedera Dx S.A. | Région Lémanique (region) |
| Lehuu, Bertrand (BioXell 200703– CBO before 25y pharma industry incl Global Licensing Director at Roche in Basel) | Chief Business Officer (CBO) | Cosmo Pharmaceuticals (Group) | Lombardia (Lombardy) |
| Leisner, Christian (CDR-Life 202204 CEO) | Chief Executive Officer (CEO) | CDR-Life AG | Zürich (region) |
| Lendi, Pietro (Bruker 201104 VP RnD Bruker BioSpin CH) | Research & Development Manager | Bruker (Group) | Espace Mittelland (region) |
| Leo, Chandra P. (HBM 201810) | Investment Manager | HBM (Group) | Central Switzerland (region) |
| Leo, Giovanni (EFI Lake Geneva Ventures I 202306 Partner + EBAMed 202306 Co-Founder + Chair) | Partner (venture partner) | ||
| Leoni, Lorenzo (TiVenture Fund 201802 Managing Director + Gain Therapeutics 201802– interim CEO before Telormedix) | Managing Director | Fondazione Centenario BancaStato | |
| Levett, Hernán (Polyphor 202001 CFO) | Chief Financial Officer (CFO) | Spexis (Group) | Northwestern Switzerland (region) |
| Levick, Mark (Novartis 200807 Head Novartis Biologics) | n. a. | Novartis (Group) | Northwestern Switzerland (region) |
| Levy, Frederic (Debiopharm 202003 Executive Director of Search + Evaluation + Scientific Innovation) | n. a. | Debiopharm (Group) | Région Lémanique (region) |
| Lewis, Seth (Molecular Partners 202112 before Bavarian Nordic 201703 VP Investor Relations US) | Public Relations Manager / Investor Relations Manager | Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) | Zürich (region) |
| Lichtenberg, Jan (InSphero 201401 CEO + Co-founder) | Chief Executive Officer (CEO) | InSphero (Group) | Zürich (region) |
| Lifton, Richard P. (Roche 201503– Board Member) | Board member, non-executive | Roche (Group) | Northwestern Switzerland (region) |
| Lindemann, Michael (bio.logis 2009– Managing Director before IBM before Siemens Medical before Genedata) | Managing Director | Genedata (Group) | Northwestern Switzerland (region) |
| Lindemeier, Jürgen (Xiril 201007 CEO) | Chief Executive Officer (CEO) | Tecan (Group) | Zürich (region) |
| Linnertz, Holger (Mettler-Toledo 200712 Head LabX Competence Center) | Product Manager (personnel) | Mettler-Toledo (Mettler Toledo) (Group) | Zürich (region) |
| Litz, Eugenia (ADC Therapeutics 202201 before Ipsen + AstraZeneca + BioMarin + Thomas Weisel + Avondale Partners) | Public Relations Manager / Investor Relations Manager | ADC Therapeutics (Group) | Région Lémanique (region) |
| Loiret-Bernal, Cédric (GeneProt 200009 CEO) | Chief Executive Officer (CEO) | GeneProt Inc. | Région Lémanique (region) |
| Longchamp, Pascal (Evolva 201201–201712 CBO TO STEP DOWN unitl end 2017) | Chief Business Officer (CBO) | Lallemand (Group) | Northwestern Switzerland (region) |
| Lonnen, Rana (Novartis 202009 Stragetic Venture Capital at Novartis Pharma) | Investment Manager | Novartis (Group) | Northwestern Switzerland (region) |
| Looi, Liew Yew (Nycomed 201011 SVP North Asia) | Regional manager | Takeda (Group) | Zürich (region) |
| Lopriore, Stefano (STMicroelectronics 200506) | n. a. | STMicroelectronics (Group) | Région Lémanique (region) |
| Loshbaugh, Amanda (ADC Therapeutics 202301 Investor Relations) | Public Relations Manager / Investor Relations Manager | ADC Therapeutics (Group) | Région Lémanique (region) |
| Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) | Chief Executive Officer (CEO) | ObsEva (Group) | Région Lémanique (region) |
| Loven, Jakob (Nextech Invest 201904 Partner) | Partner (venture partner) | Nextech (Group) | Zürich (region) |
| Lu, Patrick (Sirnaomics 202107 CEO + Founder before Novartis + Digene + Intradigm) | Chief Executive Officer (CEO) | Sirnaomics (Group) | Maryland (federal state) |
| Lubenow, Helge (Proteomedix 202001– CEO before Consultant before 1997–2015 at Qiagen) | Chief Executive Officer (CEO) | Proteomedix AG | Zürich (region) |
| Ludemann-Hombourger, Olivier (PolyPeptide 202305 Director Global Innovation + Technology) | President/Director/Head Business Group/Unit/Division | PolyPeptide (Group) | Central Switzerland (region) |
| Lun, Klaus (Tecan 201612– promoted to Head of Life Sciences joined 201306 before Molecular Devices + Leica Microsystems) | President/Director/Head Business Group/Unit/Division | Tecan (Group) | Zürich (region) |
| Lutz, Phillipe (Telormedix 201005– CFO before Synosia Therapeutics CFO before Credit Suisse) | Chief Financial Officer (CFO) | Telormedix S.A. | Ticino (region) |
| Lynch, Mike (Invoke Capital Founder) | Chief Executive Officer (CEO) | Invoke Capital (Myke Lynch) | East of England (region) |
| Lüthi, Lisa (Zur Rose Group 202007 Head of Group Communications) | Public Relations Manager / Investor Relations Manager | Zur Rose Group (Group) | Eastern Switzerland (region) |
| Lütjens, Robert (Addex 201802 Head of Discovery) | management (personnel) | Addex (Group) | Région Lémanique (region) |
| Lütolf, Michael (Verve Capital Partners 202002 investiere) | n. a. | Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) | Central Switzerland (region) |
| Läubli, Markus (Metrohm 201411 Manager Marketing Support IC) | Support Manager / Service Manager | Metrohm (Group) | Eastern Switzerland (region) |
| Machielse, Ben (Mosanna Therapeutics 202207 Board Chair before Vtesse + Omthera Pharmaceuticals) | Board member, non-executive | Mosanna Therapeutics AG | Northwestern Switzerland (region) |
| Maciejewski, Rob Konrad (Biolytica 202209 CEO + Co-Founder) | Chief Executive Officer (CEO) | Biolytica AG | Central Switzerland (region) |
| Mack, Mike (Syngenta – 201510 CEO before COO STEPPED DOWN 10/15) | Chief Executive Officer (CEO) | Syngenta (Group) | Northwestern Switzerland (region) |
| Maggos, Chris (BioConfidant / Cohesion Bureau 202303 Managing Director + Founder before LifeSci Advisors + Addex) | Public Relations Manager / Investor Relations Manager | BioConfidant (Group) | Région Lémanique (region) |
| Magni, Guido (Versant Ventures 201404 Venture Partner in Basel) | Venture Partner | Versant Ventures | Northwestern Switzerland (region) |
| Makhijani, Vinod (Roche 201506 VP + Project Leader at Roche Sequencing Business Development) | Business Development Manager / Strategy Manager | Roche (Group) | Northwestern Switzerland (region) |
| Mallik, Ameet (ADC Therapeutics 202205– CEO before Rafael Holdings + 16y at Novartis + McKinsey & Co) | Chief Executive Officer (CEO) | ADC Therapeutics (Group) | Région Lémanique (region) |
| Malloy, Patrick (Abivax 202308– SVP Investor Relations before VectivBio + Arena Pharmaceuticals + Alexion) | Public Relations Manager / Investor Relations Manager | Abivax (Group) | Île-de-France (region) |
| Malmström, Johan (Biognosys 200809– CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bruker (Group) | Zürich (region) |
| Man, Anthony (Basilea Pharmaceutica –201212 CEO RESIGNED 12/12) | Chief Executive Officer (CEO) | Basilea (Group) | Northwestern Switzerland (region) |
| Mann, Jessica (Roche 201008 Head Translational Medicine before Evolva before Speedel before Roche before Novartis) | Chief Medical Officer (CMO) | Roche (Group) | Northwestern Switzerland (region) |
| Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) | Event Manager / Conference Manager | Paragon (IL) (Group) | Région Lémanique (region) |
| Manth, Stefan M. (Mologen 201904– CEO prior Supervisory Board + SAB Member before Roche for 20 years | Chief Executive Officer (CEO) | Mologen (Group) | Berlin (federal state) |
| Marathe, Nisha (Roche 202105 Investment Director at Roche Venture Fund) | Investment Manager | Roche (Group) | Northwestern Switzerland (region) |
| Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder) | Board member | Octapharma (Group) | Central Switzerland (region) |
| Mariggi, Giovanni (Medicxi 202208 Partner) | Partner (venture partner) | Medicxi Ventures (formerly Index Ventures Life Sciences) | Greater London (region) |
| Marino, Daniela (Cutiss 202006 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cutiss AG | Zürich (region) |
| Markfort, Rainer (Dentons 201501– Partner before Mayer Brown Düsseldorf + White & Case Berlin) | Attorney / Lawyer | Dentons (Group) | Switzerland_other |
| Markovic, Sandra (LeadXPro 201804 Discovery Project Leader) | Research & Development Manager | LeadXPro AG | Northwestern Switzerland (region) |
| Marotta, Marco (Relief Therapeutics 202111– promoted to CBO joined with acquisition of APR Applied Pharma Research) | Business Development Manager / Strategy Manager | Relief Therapeutics (Group) | Ticino (region) |
| Marriott, Peter (SGS 201012 Global Technical & Accreditation Manager) | Technical Manager | SGS (Group) | Région Lémanique (region) |
| Marshak, Daniel R. (Tecan 201710– Board proposed before PerkinElmer + Cambrex) | Board member, non-executive | Tecan (Group) | Zürich (region) |
| Marshall, Fiona H. (Novartis 202211– President of NIBR before Merck + Heptares + Millennium Pharma + GSK) | President/Director/Head Business Group/Unit/Division | Novartis (Group) | Northwestern Switzerland (region) |
| Martello, Wan Ling (Nestlé 201402 CFO) | Chief Financial Officer (CFO) | Nestlé (Group) | Région Lémanique (region) |
| Martin, Chris (Auven Therapeutics 201506 CEO of ADC Therapeutics before CEO of Spirogen Ltd) | Managing Director | ADC Therapeutics (Group) | Région Lémanique (region) |
| Martin, Jacques-François (Parteurop Pharma 201602 President + Founder before Mymetics + Chiron Vaccines) | Chief Executive Officer (CEO) | Parteurop Pharma (FR) | Auvergne-Rhône-Alpes (region) |
| Martin, Roland (Univ Zürich 201104– Professor + Head Dept Neuroimmunology at Univ Hospital Zürich before inims Hamburg) | Professor | University of Zurich (UZH) | Zürich (region) |
| Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO) | General Partner (venture partner) | Eclosion S.A. | Région Lémanique (region) |
| Martyr, David (Tecan 201202–201903 announced CEO for 10/12 before Leica Microsystems RETIRED 4/19) | Chief Executive Officer (CEO) | Tecan (Group) | Zürich (region) |
| Massari, Nate (Anjarium Biosciences 202207– CBO before Aytu BioPharma + Rumpus Therapeutics + JnJ + Endo Pharma) | Chief Business Officer (CBO) | Anjarium Biosciences AG | Zürich (region) |
| Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers) | Chief Executive Officer (CEO) | Saphetor S.A. (VarSome) | Région Lémanique (region) |
| Massuyeau, Laurent (Addex 200804–200909 Head Business Developm before Idenix RESIGNED 9/09 at Addex) | Business Development Manager / Strategy Manager | Addex (Group) | Région Lémanique (region) |
| Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director) | Managing Director | Celonic (Group) | Northwestern Switzerland (region) |
| Matheis, Georg (Stimit AG 202104 Board Director) | Board member, non-executive | Dräger (Group) | Espace Mittelland (region) |
| Matillon, Valentin (Sophia Genetics 201801– CFO before Hobart Group + SITA + Electronic Arts + Hewlett-Packard Europe) | Chief Financial Officer (CFO) | Sophia Genetics (Group) | Région Lémanique (region) |
| Matter, Alex (Singapore (govt) 201310 CEO ETC of A*STAR before Novartis Global Head Oncology Research) | Chief Executive Officer (CEO) | Singapore (govt) | Singapore (cl=4) |
| Mattil, Evi (Cryo-Save 201302– Chief Commercial Officer before Amoena + IMS Health (DE) + Chiron Vaccines) | Chief Commercial Officer (CCO) | Cryo-Save AG (CH) | Central Switzerland (region) |
| Mattingly, Quincy | Business Development Manager / Strategy Manager | Elchrom Scientific AG | Central Switzerland (region) |
| Mauvernay, Rolland-Yves (Debiopharm 201301 President + Founder) | President/Director/Head Business Group/Unit/Division | Debiopharm (Group) | Région Lémanique (region) |
| Mauvernay, Thierry (Debiopharm 201306 Board Member) | Board member | Debiopharm (Group) | Région Lémanique (region) |
| Mayr, Andreas (Endress+Hauser 201606– Executive Board Member + Corp Director Marketing + Technology) | Chief Technology/Technical Officer (CTO) | Endress+Hauser (Group) | Northwestern Switzerland (region) |
1 2 3 4 5 6 7 8 9 10 11 12 13
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
